Reply to: Familial Hypermanganesemia in Iran
Sign Up to like & getrecommendations! Published in 2023 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13719
Abstract: We thank Tabatabaee et al for their interest in our work and congratulate the authors on reporting five new patients with hypermanganesemia with dystonia (HMNDYT), three of whom had HMNDYT1 and two with HMNDYT2. Similar… read more here.
Keywords: oral iron; familial hypermanganesemia; iron; reply familial ... See more keywords
Polycythemia vera masked due to severe iron deficiency anemia.
Sign Up to like & getrecommendations! Published in 2018 at "Hematology/oncology and stem cell therapy"
DOI: 10.1016/j.hemonc.2016.08.007
Abstract: Polycythemia vera is one of the chronic myeloproliferative diseases and very few patients present with its actual clinical manifestations. The most common findings are increased red cell mass and an increased leukocyte count with decreased… read more here.
Keywords: polycythemia vera; vera masked; due severe; polycythemia ... See more keywords
Impact of interferon on a triple positive polycythemia vera
Sign Up to like & getrecommendations! Published in 2019 at "Leukemia"
DOI: 10.1038/s41375-019-0636-0
Abstract: Sir, We read the paper by Julia Czech et al., “JAK2V617F but not CALR mutations confer increased molecular responses to interferonvia JAK1/STAT1 activation” [1], with great interest. This paper reports that JAK2V617Fmutated patients with myeloproliferative… read more here.
Keywords: week; impact interferon; polycythemia vera; polycythemia ... See more keywords
Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis
Sign Up to like & getrecommendations! Published in 2022 at "Scientific Reports"
DOI: 10.1038/s41598-022-08606-1
Abstract: Red cell overproduction is seen in polycythemia vera (PV), a bone marrow myeloproliferative neoplasm characterized by trilinear cell proliferation (WBC, platelets), as well as in secondary erythrocytosis (SE), a group of heterogeneous disorders characterized by… read more here.
Keywords: polycythemia vera; secondary erythrocytosis; polycythemia; icd code ... See more keywords
Prevalence of elevated hemoglobin and hematocrit levels in patients with obstructive sleep apnea and the impact of treatment with continuous positive airway pressure: a meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Hematology"
DOI: 10.1080/16078454.2022.2109346
Abstract: ABSTRACT Objectives Obstructive sleep apnea (OSA) is reported to be a cause of secondary polycythemia. The present study (i) reviewed the literature reporting the prevalence of secondary polycythemia in patients with OSA and (ii) determined… read more here.
Keywords: hematocrit levels; prevalence; analysis; polycythemia ... See more keywords
Prevalence and diagnostic performance of iron deficiency in polycythemia.
Sign Up to like & getrecommendations! Published in 2023 at "Hematology"
DOI: 10.1080/16078454.2023.2204621
Abstract: INTRODUCTION Several observations have shown that patients with polycythemia have iron deficiency. Our objectives were to report the prevalence of iron deficiency and to evaluate the diagnostic performance of serum ferritin in polycythemia vera. PATIENTS… read more here.
Keywords: iron deficiency; prevalence; polycythemia; diagnostic performance ... See more keywords
The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin–angiotensin system inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2022.2045958
Abstract: ABSTRACT Introduction Although polycythemia has been considered a common adverse event in COPD, anemia is reported more often and has gained more importance than polycythemia over the last thirty years. Areas covered Factors considered to… read more here.
Keywords: anemia copd; polycythemia; polycythemia anemia; shift polycythemia ... See more keywords
Gaisböck syndrome (polycythemia and hypertension) revisited: results from the national inpatient sample database
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000001805
Abstract: Background: Polycythemia is characterized by increased blood viscosity and a chronic inflammatory state possibly giving rise to excessive thromboembolic events and hypertensive cardiovascular disease. We aimed to study the relationship between polycythemia and cardiac risk… read more here.
Keywords: inpatient sample; national inpatient; cardiac risk; hypertension ... See more keywords
Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single‐centre analysis
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16759
Abstract: and polycythemia vera. J Hematol Thromb Dis. 3. 5. Silver RT, Krichevsky S. Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values. Haematologica. 2019;104:2200–5. 6. Johansson PL, Safai-Kutti S, Kutti J. An elevated… read more here.
Keywords: ibrutinib patients; polycythemia vera; analysis; polycythemia ... See more keywords
Translational repression of HIF2&agr; expression in mice with Chuvash polycythemia reverses polycythemia
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Investigation"
DOI: 10.1172/jci97684
Abstract: Chuvash polycythemia is an inherited disease caused by a homozygous germline VHLR200W mutation, which leads to impaired degradation of HIF2&agr;, elevated levels of serum erythropoietin, and erythrocytosis/polycythemia. This phenotype is recapitulated by a mouse model… read more here.
Keywords: hif2 agr; agr expression; mice; polycythemia ... See more keywords
ACE inhibitors and cytoreductive therapy in polycythemia vera.
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood-2016-11-752600
Abstract: To the editor: In a large international cohort of contemporary polycythemia vera (PV) patients[1][1] recruited at diagnosis and treated according to European LeukemiaNet recommendations,[2][2] the postdiagnosis total major thrombosis rate was 2.62% patients per year,… read more here.
Keywords: polycythemia vera; cytoreductive therapy; inhibitors cytoreductive; ace inhibitors ... See more keywords